Bullish option flow detected in Apellis Pharmaceuticals with 2,842 calls trading, 2x expected, and implied vol increasing over 1 point to 50.60%. Apr-23 65 calls and Apr-23 70 calls are the most active options, with total volume in those strikes near 2,200 contracts. The Put/Call Ratio is 0.03. Earnings are expected on May 3rd.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on APLS:
- Apellis price target lowered to $88 from $91 at Citi
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Option to Purchase Additional Shares
- Sell these stocks now, proven algorithm says
- Apellis 3.17M share Spot Secondary priced at $63.00